Variations in the diagnostic performance of transurethral resection of bladder tumor with photodynamic diagnosis according to surgical experience: A retrospective, single-center study

Autor: Shuhei Suzuki, Yoshiyuki Nagumo, Kosuke Kojo, Atsushi Ikeda, Bunpei Isoda, Akane Yamaguchi, Kozaburo Tanuma, Satoshi Nitta, Masanobu Shiga, Takashi Kawahara, Shuya Kandori, Akio Hoshi, Hiromitsu Negoro, Bryan J. Mathis, Hiroyuki Nishiyama

Publikováno v: Photodiagnosis and Photodynamic Therapy, Vol 51, Iss , Pp 104429- (2025)

Background: To investigate variations in diagnostic performance of photodynamic diagnosis (PDD) according to surgical experience. Methods: Data were extracted from patients having pT1 or lower primary tumors that underwent PDD-assisted transurethral

Externí odkaz: https://doaj.org/article/bd6b3b40c22d48b1a472986cb27ac903

TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab.

Autor: Isoda, Bunpei¹ (AUTHOR) bunpeiisoda@gmail.com, Kandori, Shuya¹ (AUTHOR) n.satoshi19880320@gmail.com, Sazuka, Tomokazu² (AUTHOR) tomo1ata2@yahoo.co.jp, Kojima, Takahiro³ (AUTHOR) t.kojima@aichi-cc.jp, Nitta, Satoshi¹ (AUTHOR) baseball4420002001@yahoo.co.jp, Shiga, Masanobu¹ (AUTHOR) nagumoyoshiyuki@gmail.com, Nagumo, Yoshiyuki¹ (AUTHOR) nishiuro@md.tsukuba.ac.jp, Fujimoto, Ayumi² (AUTHOR) ayuroom@gmail.com, Arai, Takayuki² (AUTHOR) takataka50423@gmail.com, Sato, Hiroaki² (AUTHOR) hhiirrooaakkii14@yahoo.co.jp, Mathis, Bryan J.⁴ (AUTHOR) bmathis@md.tsukuba.ac.jp, Wu, Chia-Ling⁵ (AUTHOR) jalinwu@actgenomics.com, Jan, Yi-Hua⁵ (AUTHOR) isaacjan@actgenomics.com, Ichikawa, Tomohiko² (AUTHOR) tomohiko_ichikawa@faculty.chiba-u.jp, Nishiyama, Hiroyuki¹ (AUTHOR)

Publikováno v: International Journal of Molecular Sciences. Jul2024, Vol. 25 Issue 13, p7444. 15p.

Reports Summarize Carcinomas Research from University of Tsukuba (TNFSF9 Is Associated with Favorable Tumor Immune Microenvironment in Patients with Renal Cell Carcinoma Who Are Treated with the Combination Therapy of Nivolumab and Ipilimumab).

Publikováno v: Immunotherapy Weekly; 7/23/2024, p839-839, 1p

New Urothelial Cancer Research from University of Tsukuba Discussed (Complete Response to Enfortumab Vedotin in a Hemodialysis Patient with Metastatic Urothelial Carcinoma: A Case Report).

Publikováno v: Clinical Oncology Week; 6/27/2023, p680-680, 1p